Author

Aurélie Gennetier

InsermORCID 0000-0002-8681-4341Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adeline TorroiD· 1 shared Benoît MiottoiD· 1 shared Céline GongoraiD· 1 shared Cyril RibeyreiD· 1 shared Diégo TosiiD· 1 shared Eric JulieniD· 1 shared Fatima AlhouraniiD· 1 shared Florence M. CammasiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adeline TorroORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting SUV4-20H epigenetic enzymes as therapeutic strategy for enhancing topoisomerase II poisoning in prostate cancer

Fatima Alhourani, Marine Tauziet, Julie Patouillard, Benoît Miotto, Véronique Baldin, Aurélie Gennetier, Simon George, Xavier Mialhe, Cyril Ribeyre, Philippe Pourquier, Florence M. Cammas, Adeline Torro, Diégo Tosi, Céline Gongora, Mona Dergham, , Eric Julien

This study shows that inhibiting SUV4-20H enzymes enhances the effectiveness of TOP2 poisons in prostate cancer by increasing DNA damage and impairing repair mechanisms.

bioRxiv · Mar 11, 2025 · PreprintCancer Biology